Month: <span>March 2022</span>

Home / 2022 / March
Can drugs reduce the risk of long COVID? What scientists know so far
Post

Can drugs reduce the risk of long COVID? What scientists know so far

25 March 2022 Researchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms. Heidi Ledford Researchers are studying the long-term effects of treatments given to people hospitalized with COVID-19.Credit: Diego Vara/Reuters In the early days of the COVID-19 pandemic, urologist and clinical epidemiologist Kari Tikkinen found his schedule full of...

Post

AI REVEALS LINK BETWEEN FAMILY HISTORY AND TYPE 1 DIABETES RISKS

MARCH 28TH, 2022; POSTED BY ERIC STANN-MISSOURI “Type 1 diabetes is not a single disease that looks the same for everybody—it looks different for different people,” says Tallon. “By analyzing real-world data, we can better understand risk factors that may cause someone to be at higher risk for developing poor health outcomes.” UNIVERSITY OF MISSOURI...

Preventing untimely deaths from non-communicable diseases
Post

Preventing untimely deaths from non-communicable diseases

by  University of Washington School of Medicine Figure 1. Achievable reductions in cause-specific mortality from scale-up of priority NCD interventions across low-income and middle-income countries The density plots show the distribution of the rate of change in cause-specific mortality across all 123 low-income and middle-income countries. We compare historical (2015–19) average annual rates of change to...

Will Omicron finally overpower China’s COVID defences?
Post

Will Omicron finally overpower China’s COVID defences?

The country needs to control the virus until it has boosted vaccination rates in elderly people and reinforced the health-care system. By Dyani Lewis In some parts of China, barricades have been set up around communities with high numbers of COVID-19 cases. Credit: Kevin Frayer/Getty All eyes are on China as it attempts to quash...

Post

E-CIGARETTES REVERSED 20 YEARS OF DECLINE IN TEEN NICOTINE USE

MARCH 25TH, 2022; POSTED BY MORGAN SHERBURNE-MICHIGAN “The recent rise in adolescent e-cigarette use, and growing numbers of adolescents who try to quit e-cigarettes and fail, have eroded much of this decline in adolescents who struggle with nicotine,” says Richard Miech. UNIVERSITY OF MICHIGAN The number of adolescents who have attempted to quit e-cigarettes and...

Post

Elderly care? Bring in the robots!

Robots have come a long way. For years they have been supporting human activity – enabling exploration in dangerous and unreachable environments like out in space and deep in the oceans. A new generation of robots are being designed to stay closer to home – caring for ageing adults and young children. In the not-too-distant future, elderly...

Post

How flossing and brushing may be good for your lungs

From chewing sticks to using twigs, hog bristles and horsehair, people have been polishing their pearly whites for millennia. Now EU scientists are investigating whether good oral hygiene can also protect us from chronic lung diseases. They’re also checking what our saliva says about our overall health. Did you ever think that a simple task like brushing...

Device Makes Diffuse Ultrasound Waves for Intracranial Applications
Post

Device Makes Diffuse Ultrasound Waves for Intracranial Applications

MARCH 28TH, 2022   CONN HASTINGS Researchers at the University of California San Diego created an ultrasound transducer that is intended to provide safer ultrasound treatment when working inside the brain. Ultrasound has significant therapeutic potential for various ailments that originate in the brain, including epilepsy, and next-level sonogenetics involves targeting various cell types in the brain...

First use of mRNA COVID vaccine to treat persistent SARS-CoV-2 infection
Post

First use of mRNA COVID vaccine to treat persistent SARS-CoV-2 infection

By Rich Haridy; March 27, 2022 The man tested positive to SARS-CoV-2 for 218 days. IC: Depositphotos A new case report published in the Journal of Clinical Immunology has presented the first description of a mRNA COVID-19 vaccine being used to therapeutically treat a patient experiencing a persistent SARS-CoV-2 infection. The immunocompromised patient, who repeatedly tested positive...